Sanofi pursues sale of painkiller after political controversy
==========

Sanofi plans to sell a controlling 50-percent stake in its over-the-counter unit Opella to US investment fund CD&R, valuing the deal at 16 billion euros ($17.4 billion); French Economy Minister Antoine Armand confirmed employment and investment guarantees were met; the sale follows political controversy and concerns over 1,700 jobs in France; Opella employs over 11,000 workers globally and operates in 100 countries; Doliprane is France's leading painkiller; the deal is expected to finalize in Q2 2025; Bpifrance to take a 2-percent stake post-sale.

#Sanofi #Opella #Doliprane #Cd&r #France #Pharmaceuticals #Investment #Politics #Healthcare #Jobs

https://www.legit.ng/business-economy/economy/1620422-sanofi-pursues-sale-painkiller-political-controversy/